CONTROL SUB-OPIOIDS-COMPLIANCE House SponsorsRep. Dagmara Avelar-Eva-Dina Delgado-William E Hauter, Chris Miller, Camille Y. Lilly, Yolonda Morris and Anne Stava-Murray Senate Sponsors(Sen. Suzy Glowiak Hilton, Steve McClure-Linda Holmes and Sally J. Turner) 8/2/2024HousePublic Act . . . . . . . . . 103-0732 720 ILCS 570/311.6 Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of this Section occurs. Effective immediately.House Committee Amendment No. 1 Provides that compliance action with respect to the statute concerning opioid prescriptions initiated by the Department of Financial and Professional Regulation prior to December 31, 2030 is limited to a non-disciplinary warning letter or citation, unless the prescriber or dispenser (rather than just the prescriber) fails to abide by the initial non-disciplinary warning letter or citation, has acted in bad faith, or a pattern of practice in violation of the statute concerning opioid prescriptions occurs. 2/6/2024HouseFiled with the Clerk by Rep. Dagmara Avelar 2/7/2024HouseFirst Reading 2/7/2024HouseReferred to Rules Committee 2/28/2024HouseAssigned to Public Health Committee 3/1/2024HouseAdded Co-Sponsor Rep. William E Hauter 3/1/2024HouseRemoved Co-Sponsor Rep. William E Hauter 3/7/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar 3/7/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee 3/20/2024HouseHouse Committee Amendment No. 1 Rules Refers to Public Health Committee 4/4/2024HouseHouse Committee Amendment No. 1 Adopted in Public Health Committee; by Voice Vote 4/4/2024HouseDo Pass as Amended / Short Debate Public Health Committee; 009-000-000 4/4/2024HousePlaced on Calendar 2nd Reading - Short Debate 4/10/2024HouseAdded Co-Sponsor Rep. Chris Miller 4/11/2024HouseAdded Chief Co-Sponsor Rep. Eva-Dina Delgado 4/11/2024HouseSecond Reading - Short Debate 4/11/2024HousePlaced on Calendar Order of 3rd Reading - Short Debate 4/15/2024HouseAdded Chief Co-Sponsor Rep. William E Hauter 4/16/2024HouseAdded Co-Sponsor Rep. Camille Y. Lilly 4/16/2024HouseAdded Co-Sponsor Rep. Yolonda Morris 4/16/2024HouseAdded Co-Sponsor Rep. Anne Stava-Murray 4/18/2024HouseThird Reading - Short Debate - Passed 114-000-000 4/19/2024SenateArrive in Senate 4/19/2024SenatePlaced on Calendar Order of First Reading 4/19/2024SenateChief Senate Sponsor Sen. Suzy Glowiak Hilton 4/19/2024SenateFirst Reading 4/19/2024SenateReferred to Assignments 4/30/2024SenateAssigned to Licensed Activities 4/30/2024SenateAdded as Alternate Co-Sponsor Sen. Steve McClure 4/30/2024SenateRule 2-10 Committee Deadline Established As May 10, 2024 5/8/2024SenateDo Pass Licensed Activities; 007-000-000 5/9/2024SenatePlaced on Calendar Order of 2nd Reading May 14, 2024 5/14/2024SenateSecond Reading 5/14/2024SenatePlaced on Calendar Order of 3rd Reading 5/15/2024SenateAdded as Alternate Chief Co-Sponsor Sen. Linda Holmes 5/15/2024SenateThird Reading - Passed; 057-000-000 5/15/2024HousePassed Both Houses 5/15/2024SenateAdded as Alternate Co-Sponsor Sen. Sally J. Turner 6/13/2024HouseSent to the Governor 8/2/2024HouseGovernor Approved 8/2/2024HouseEffective Date August 2, 2024 8/2/2024HousePublic Act . . . . . . . . . 103-0732